EQTs 0.73% Rally Amid 392nd Volume Rank Fuels 2.1 Billion Franc Galderma Divestiture

On July 31, 2025, EQT (EQT) closed with a 0.73% rise, trading at a volume of $0.38 billion, a 33.82% drop from the prior day, ranking 392nd in market activity. The stock's performance coincided with the completion of a major equity transaction involving its stake in Galderma Group AG.

EQT successfully concluded the sale of 17 million shares in Galderma Group AG via an accelerated bookbuilding process, generating total gross proceeds of approximately CHF 2.1 billion. The firm directly received CHF 555 million from the placement, which was finalized on July 31. The transaction, led by a consortium of global financial institutions including BNP Paribas, Citigroup, Goldman Sachs, Jefferies, Morgan Stanley, and UBS, underscored strong institutional demand for Galderma's dermatological healthcare assets.

The strategic divestiture aligns with EQT's focus on optimizing capital returns while maintaining its position as a global investment leader managing EUR 266 billion in assets. The sale reflects confidence in Galderma's market leadership and EQT's ability to execute high-value transactions efficiently. The absence of registration requirements for U.S. securities in the offering highlights the transaction's compliance with international regulatory frameworks.

The strategy of purchasing the top 500 stocks by daily trading volume and holding them for one day delivered a 166.71% return from 2022 to July 30, 2025. This approach outperformed the benchmark return of 29.18%, generating an excess return of 137.53%. The strategy's success is attributed to its ability to capture market momentum effectively while managing risk, as evidenced by the consistent high returns despite varying market conditions.